OncLive - Bringing the Oncology Community Together

Home

Targeted Therapies

Hennessy's Highlights

November 2011

From the Editor

Colorectal Tumor Marker: Molecular Evaluation Sheds Light on Negative Lymph Node Status

Pathways

5 Questions for Martin Steffen, MD, PhD

Phosphorylation: The Master Switch of the Cell

Profiles in Research

Channeling His Creativity Into Oncology: A "Renaissance Man" Makes a Mark in Lymphoma Research

Specialty Focus

Emerging Biomarker Science Presents Practical Questions

HPV Vaccine Recommendation for Boys Viewed as Necessary

Planned Cooperative Group Merger Is Generating Concern

New Assays Open Window in Evaluating Leukemia Types

Using Molecular Markers in AML for Prediction, Treatment, and Monitoring

Hypofractionated Radiation Trial Results Comparable to Standard in Intermediate - and High-Risk Patients

Cover Story

From Warfare to Mainstay: Mustard Derivatives Play Evolving Role in Cancer Therapy

Feature Article

Internet Site Helps Oncologists Bridge Patients' Knowledge Gap: An Interview with April Latrice Speed, MD

External Resources

American Journal of Managed Care
HCPLive
PainLive
Pharmacy Times
Physicians' Education Resource
Physician's Money Digest

OncLive Resources

Archives
Blogs
OncLive TV
Oncology Nurses
Publications
Specialties
Web Exclusives

About Us
Advertise
Advisory Board
Contact Us
Forgot Password
Privacy Policy
Terms & Conditions

Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright HCPLive 2006-2012
Intellisphere, LLC. All Rights Reserved.